Track the Shanghai Bio-heart Biological Technology Co., Ltd. - B -H Sh stock price and the full directors' dealings record of the company, a listed issuer based in Hong Kong. Shares trade on the HK market, under the oversight of HKEX. Market capitalisation: €14.5bn. The latest transaction was filed on 24 July 2026 (Purchase). Among the most active insiders: Wang Philip Li. Every trade is free.
45
Insider Decl.
n/a
Thresholds
€1m
45 ops.
Buy Volume
n/a
n/a
Sell Volume
11Σ signal
Buys €1mn/a Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 12,600 of 28,892 companies
55.3
score / 100
Value
87
Quality
24
FCF yld38%
Earn yld8.3%
EV/EBITDA6.5x
ROE·
Gross mgn18%
Net mgn1.0%
Debt/EBITDA5.0x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
10,000 shares@ HK$2.560.3% of flowShareXHKGHKEX:DA20260617E00070
25 of 45 declarations
About Shanghai Bio-heart Biological Technology Co., Ltd. - B -H Sh
Shanghai Bio-heart Biological Technology Co., Ltd. is a company focused on the development of biological technologies. It specializes in the research and production of innovative biological products.